Francisco Torrens is lecturer in physical chemistry at the Universitat de Valencia. After obtaining a PhD in molecular associations in azines and macrocycles from the Universitat de Valencia, Dr. Torrens undertook postdoctoral research with Professor Rivail at the Universite de Nancy I. More recently, Dr. Torrens has collaborated on projects with Professors Tomas-Vert, Salgado and Castellano. Major research projects include prediction of the environmental impact of chemical substances using chemobioinformatics tools, discovery of new inhibitors of tyrosinase: computational design, synthesis, characterization and experimental corroboration, search for new antimicrobial agents that inhibit the synthesis of the bacterial cell wall, minimal active domains of proteins of the Bcl 2 family, development and application of quantum chemistry methods and techniques to studies of drugs, analysis of pores of BAX at nanometric scale and study of the in vivo antioxidant capacity of phenolic compounds through QSAR/QSPR modelling: crossing of the blood-brain barrier and interactions with cytochromes and drugs. His scientific accomplishments include the first implementation in a computer at the Universitat de Valencia of a program for the elucidation of crystallographic structures and the construction of the first computational-chemistry program adapted to a vector-facility supercomputer in a Spanish university.
Molecular Simulations & Modelling Physical Chemistry Computer-Aided Drug Design
Dr. Sorush Niknamian PhD MRSB FChE FNNECOS FTSCO Ph.D. in Cell and Molecular Biology and Oncology and Professor of Cell and Molecular Biology, Oncology and Biological Attacks. He is a Professional Biologist, Senior Research Scientist, Chartered Scientist and Registered Scientist at Violet Cancer Institute (VCI). His Science Council ID is: A-0008833. He is one of United Kingdom and Indiana Cancer Consortium (ICC) certified. He is a Registered Researcher in the U.S. Government's System for Award Management, Registered Scientist at National Center for Biotechnology Information. He is studying Medicine/Military Medicine at Liberty University (LU), Lynchburg, VA, United States of America. He holds Bachelor's Degree in Mechatronics Engineering, applied Mathematics, Civil Engineering and Management. He is a Member of US Government National Science Foundation, Member of Hera Swiss Volunteers (ID: 198036), Member of US Army American College of Physicians Chapter, Ambassador of American Cancer Society (ACS CAN) and former Ambassador of European Association for Cancer Research (EACR), Active Member of Federal Health Professionals at US Army Forces and Certified Member of American Red Cross and Food Regulatory Affairs Professionals. He is a Board Member and contributor of Weston A Price Foundation co-founded in 1999 by Sally Fallon (Morell) and nutritionist Mary G. Enig. PhD. He Holds Honorary Doctorate of Cancer Biology and Doctor of Science from Violet Cancer Institute. He is preserved and nominated for the preserved as Position Title: DIRECTOR OF MILITARY SUPPORT, Agency: Army National Guard Units. Announcement Number: ID: WA-10507254-AR-19-161. Extra Information: DIRECTOR OF MILITARY SUPPORT located at the WASHINGTON J3 DCSOPS. Professor Sorush Niknamian is an ACP Chapter member in United States Army and Air Force. Active Member of IMRTC-USA (International Management Research and Technology Consortium Research) as Advisor, Referee, Professor at IMRTC-USA (International Management Research and Technology Consortium Panel.
Dr. Sorush Nik Namian prime research interest is working on the prime cause, prevention and treatment of cancer. Beside this, respiratory medicine, neurological disorders, psychological disorders and their relation to cancer, Evolutionary biology and medicine, Biochemistry, Viral and Fungal diseases, Intravenous Ozone Therapy, multiple Sclerosis, Dementia, Chronic fear and anxiety disorders and their relation to metabolic diseases like cancer, Cancer Biology, bio-medicine, introducing and connecting theoretical physics like quantum entanglement to the field of biology.
Mikhaylov Vladimir was born on March 21, 1959 in Uglich, Yaroslavl province, Russia Professional experience: 1976- 1982- has finished the Ryazan medical institute named after I.P. Pavlov. 1982-1983- Emergency Hospital Ryazan medical interns surgical department 1983-1985 - Regional Hospital of Kozmodemyansk, Mari ASSR -surgical oncologist 1985-1989- Regional Cancer Hospital, Ryazan surgical oncologist 1989-1987 - State Research Center of Laser Medicine, Moscow, Senior Research Fellow, Department of Surgery of the biliary tract and parenchymal organs, 1994 - is nominated as the conducting scientific employer, Department of Surgery of the esophagus and stomach. 1997-2000 - Head of Moscow Scientific-Practical Center of laser Medicine. 2000-2006 -General director of Scientific medical laser Center, Moscow. Since 2006 - private practices on family medicine in Moscow. 2013- Physician Contract with Eternity Medicine Institute, Dubai. ). He has published over 30 peer reviewed articles.
Low Level Laser Therapy (LLLT) for the treatment from cancer diseases
Cancer Institute, Aristide Le Dantec Hospital, Dakar, Senegal
El Hadji Seydou Mbaye
Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France).
Women genital sphere infections, Cancer, Viruses, Immunology, Pesticides and cancer, Human Bio-banking, Vaccines and Vaccination Program, Microbiology
Zhongke Jianlan Medical Institute, Hangzhou, China
Dr. Chong Li, Ph.D of Peking University, currently Professor of the Institute of Biophysics, CAS and Director of the Medical Immunodiagnostic Research Center the Institute of Biophysics, CAS, was born in 1972. He has a long career in basic and translational medicine research of tumor immunology and antibody drugs. The total IF of his articles published is more than 300. Also, he has published 8 academic monographs and been authorized for more twenty patents both in China and the United States. Meanwhile, he has hosted dozens of national and local foundation projects covering the Ministry of Science and Technology of China, National Natural Science Foundation of China, Chinese Academy of Sciences, etc. He has organized to carry out several scientific and technological plans in the advanced clinical area such as China Neo-two Cancers (bladder and prostate cancers) Screening and China Bladder Cancer Precision Medicine Plan, etc. Also, he has been granted several times for Science & Technology Award, Innovation & Venue Award, etc., including The First Prize of Beijing Science and Technology Award, The First Prize of Yunnan Science and Technology Progress Award.
Transnational medicine research of tumor immunology and antibody drugs
35 Research papers have been published in many reputed journals, She is Academic visitor as a international speaker to several countries as Uk, USA, Thailand, sri Lanka, UAE, Netherlands, Canada, etec.